Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 2004;24:357-362
Published online before print December 29, 2003, doi: 10.1161/01.ATV.0000114235.51044.92
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
24/2/357    most recent
01.ATV.0000114235.51044.92v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by von der Thüsen, J. H.
Right arrow Articles by Biessen, E. A.L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by von der Thüsen, J. H.
Right arrow Articles by Biessen, E. A.L.
Related Collections
Right arrow Gene therapy
Right arrow Restenosis
Right arrow Endothelium/vascular type/nitric oxide
Right arrow Animal models of human disease
Right arrow Smooth muscle proliferation and differentiation
(Arteriosclerosis, Thrombosis, and Vascular Biology. 2004;24:357.)
© 2004 American Heart Association, Inc.


Atherosclerosis and Lipoproteins

Adenoviral Transfer of Endothelial Nitric Oxide Synthase Attenuates Lesion Formation in a Novel Murine Model of Postangioplasty Restenosis

Jan H. von der Thüsen; Madelon L. Fekkes; Robert Passier; A.J. van Zonneveld; V. Mainfroid; Theo J.C. van Berkel; Erik A.L. Biessen

From the Division of Biopharmaceutics, Leiden/Amsterdam Center for Drug Research (J.H.v.d.T., M.L.F., T.J.C.v.B., E.A.L.B.), Gorlaeus Laboratories, Department of Cardiology, Leiden University Medical Centre (J.H.v.d.T.), and Crucell Holland B.V. (R.P., A.J.v.Z., V.M.), 2333 CN Leiden, The Netherlands.

Correspondence to Jan H. von der Thüsen, Division of Biopharmaceutics, Leiden/Amsterdam Center for Drug Research, Gorlaeus Laboratories, Leiden University, Einsteinweg 55, P.O. Box 9502, 2300 RA Leiden, The Netherlands. E-mail thuesen{at}lacdr.leidenuniv.nl

Objective— Restenosis remains a major late complication of percutaneous transluminal coronary angioplasty (PTCA), for which the development of prevention strategies has thus far been hampered by the lack of a representative and practical animal model. We have, therefore, developed a murine model of PTCA-induced restenosis.

Methods and Results— Rigid probe angioplasty of pre-existing atherosclerotic lesions in the carotid arteries of ApoE-deficient mice was found to result in an increase in lesion size (0.14±0.04x105 µm2 to 0.42±0.09x105 µm2, P=0.007) with a smooth muscle cell-rich, fibrotic lesion morphology. In an additional experiment, lesions were incubated immediately after angioplasty with adenovirus bearing an endothelial nitric oxide synthase (eNOS) transgene (Ad.APT.eNOS), or an "empty" control virus (Ad.APT.empty) at a titer of 1.5x109 pfu/mL. Ad.APT.eNOS treatment was seen to lead to a 73.1% reduction in plaque size (0.27±0.04x105 µm2 versus 1.02±0.39x105 µm2, P=0.07), which translated to a significantly lowered average degree of stenosis (33.6±4.1% versus 74.6±14.0%, P=0.02). Ad.APT.eNOS also decreased lesional collagen content from 29.1% to 4.8% (P<0.001).

Conclusion— We believe that we have established a representative murine model of postangioplasty restenosis, which may serve to elucidate the mechanisms underlying restenosis and to evaluate potential antirestenotic therapies.


Key Words: atherosclerosis • restenosis • mouse model • gene therapy • eNOS




This article has been cited by other articles:


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
R. Lukowski, P. Weinmeister, D. Bernhard, S. Feil, M. Gotthardt, J. Herz, S. Massberg, A. Zernecke, C. Weber, F. Hofmann, et al.
Role of Smooth Muscle cGMP/cGKI Signaling in Murine Vascular Restenosis
Arterioscler. Thromb. Vasc. Biol., July 1, 2008; 28(7): 1244 - 1250.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
H. Suzuki, K. Eguchi, H. Ohtsu, S. Higuchi, S. Dhobale, G. D. Frank, E. D. Motley, and S. Eguchi
Activation of Endothelial Nitric Oxide Synthase by the Angiotensin II Type 1 Receptor
Endocrinology, December 1, 2006; 147(12): 5914 - 5920.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
C. Partovian, Z. Zhuang, K. Moodie, M. Lin, N. Ouchi, W. C. Sessa, K. Walsh, and M. Simons
PKC{alpha} Activates eNOS and Increases Arterial Blood Flow In Vivo
Circ. Res., September 2, 2005; 97(5): 482 - 487.
[Abstract] [Full Text] [PDF]